ATI RN
Integumentary drugs Questions
Question 1 of 5
Administration of the following eye drops/ointments can produce the correctly paired systemic effects:
Correct Answer: A
Rationale: In this question regarding the administration of eye drops/ointments and their associated systemic effects, the correct pairing is option A) Carteolol leading to bradycardia. Carteolol is a beta-blocker used to lower intraocular pressure in conditions like glaucoma, but it can also be systemically absorbed and cause bradycardia due to its effect on the heart's beta receptors. Option B) Aciclovir is an antiviral medication used to treat herpes infections and does not cause alopecia. Option C) Gentamicin is an antibiotic commonly used in eye drops for bacterial infections but is known to cause nephrotoxicity, not renal tubular necrosis specifically. Option D) Prednisolone is a corticosteroid used for inflammation and immune suppression, which can lead to many side effects, but hypercalcemia is not one of them. Educationally, understanding the systemic effects of topical medications is crucial for healthcare professionals to prevent adverse events and provide safe and effective care to patients. It highlights the importance of pharmacological knowledge, drug interactions, and monitoring for side effects when using medications across different routes of administration.
Question 2 of 5
Isotretinoin:
Correct Answer: C
Rationale: Rationale: The correct answer is C) Is teratogenic. Isotretinoin is a powerful medication commonly used to treat severe acne. It is crucial to understand that isotretinoin is teratogenic, meaning it can cause severe birth defects if taken during pregnancy. This is a critical point to emphasize because of the potential serious consequences it poses to pregnant women and their unborn babies. It is essential for healthcare providers to educate patients on the importance of reliable contraception while taking isotretinoin to prevent pregnancy and to undergo regular pregnancy tests as part of the risk management program. Now, let's analyze why the other options are incorrect: A) Is a synthetic vitamin D analogue: This statement is false. Isotretinoin is a retinoid derivative of vitamin A, not a synthetic vitamin D analogue. Understanding the correct classification of isotretinoin is essential for safe prescribing and patient education. B) The usual course of treatment is two weeks: This statement is incorrect. The usual course of isotretinoin treatment for acne typically lasts for several months, usually ranging from 4 to 6 months. Knowing the appropriate duration of treatment is crucial for achieving optimal therapeutic outcomes and managing patient expectations. D) Causes hirsutism: This statement is inaccurate. Isotretinoin is actually known to cause hair loss rather than hirsutism. Understanding the side effect profile of isotretinoin is essential for healthcare providers to counsel patients effectively and manage their expectations during treatment. Educational Context: Educating healthcare professionals and patients about isotretinoin is essential to ensure safe and effective treatment outcomes. Understanding the teratogenic nature of isotretinoin is crucial for healthcare providers to emphasize the importance of contraception and pregnancy prevention strategies. Additionally, knowledge of isotretinoin's side effects, appropriate treatment duration, and accurate drug classification are essential for safe prescribing practices and patient education. This comprehensive understanding of isotretinoin will help healthcare providers optimize patient care and minimize potential risks associated with this medication.
Question 3 of 5
The following may be effective in the management of severe psoriasis:
Correct Answer: A
Rationale: The correct answer is A) Weekly methotrexate for the management of severe psoriasis. Methotrexate is a systemic medication that is commonly used in the treatment of psoriasis due to its ability to slow down the rapid turnover of skin cells in psoriatic lesions. It is effective in reducing inflammation and controlling the symptoms of severe psoriasis. Option B) Erythromycin is an antibiotic that is not typically used in the management of psoriasis. Psoriasis is an inflammatory autoimmune skin condition, and erythromycin does not target the underlying immune system dysfunction that drives psoriasis. Option C) Efalizumab is a biologic medication that was previously used for psoriasis. However, it has been withdrawn from the market due to safety concerns, including the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. Option D) Nateglinide is a medication used to treat type 2 diabetes by stimulating insulin release from the pancreas. It is not indicated for the treatment of psoriasis as it does not address the underlying inflammatory processes in the skin. In an educational context, it is crucial for healthcare providers to understand the appropriate pharmacological management of psoriasis based on the latest evidence and guidelines. Methotrexate is a first-line systemic therapy for severe psoriasis and understanding its mechanism of action and efficacy can help healthcare professionals make informed decisions in the treatment of this chronic skin condition.
Question 4 of 5
Administration of the following eye drops/ointments can produce the correctly paired systemic effects:
Correct Answer: A
Rationale: In this question regarding the administration of eye drops/ointments and their associated systemic effects, the correct pairing is option A) Carteolol leading to bradycardia. Carteolol is a beta-blocker used to lower intraocular pressure in conditions like glaucoma, but it can also be systemically absorbed and cause bradycardia due to its effect on the heart's beta receptors. Option B) Aciclovir is an antiviral medication used to treat herpes infections and does not cause alopecia. Option C) Gentamicin is an antibiotic commonly used in eye drops for bacterial infections but is known to cause nephrotoxicity, not renal tubular necrosis specifically. Option D) Prednisolone is a corticosteroid used for inflammation and immune suppression, which can lead to many side effects, but hypercalcemia is not one of them. Educationally, understanding the systemic effects of topical medications is crucial for healthcare professionals to prevent adverse events and provide safe and effective care to patients. It highlights the importance of pharmacological knowledge, drug interactions, and monitoring for side effects when using medications across different routes of administration.
Question 5 of 5
The following treatments have been correctly paired with their licensed indication in ophthalmology:
Correct Answer: B
Rationale: The correct answer is B) Ranizumab - age-related macular degeneration. Ranizumab is a medication commonly used in ophthalmology to treat age-related macular degeneration, a condition that affects the central part of the retina and can lead to vision loss. Ranibizumab works by inhibiting vascular endothelial growth factor (VEGF), which is a key factor in the development of abnormal blood vessels in the retina. Now, let's analyze why the other options are incorrect: A) Aciclovir is an antiviral medication used to treat herpes simplex infections, including herpes keratitis, not cytomegalovirus (CMV) retinitis which is a condition commonly treated with ganciclovir. C) Ciprofloxacin is an antibiotic commonly used to treat bacterial infections, including those causing corneal ulceration. Therefore, this option is a plausible treatment choice for corneal ulceration. D) Fusidic acid is an antibiotic primarily used to treat bacterial infections of the skin and eyes, not hypersensitivity reactions. In an educational context, understanding the correct pairing of drugs with their indications in ophthalmology is crucial for healthcare professionals to provide effective and appropriate treatment to patients with eye conditions. This knowledge ensures that patients receive the right medication for their specific eye condition, leading to better outcomes and improved patient care. It also highlights the importance of accurate drug selection based on the underlying pathology of the eye disease being treated.